After vital signs stabilize and infection is controlled, the MDT evaluates the patient to formulate an individualized plan for early resumption of leukemia chemotherapy; continue G-CSF support postoperatively if needed to promote granulocyte recovery. Here, CSF3 is linked to leukemia.